CoQ10 Contraindications and Safety

Drug Interactions

The American Heart Association suggests that CoQ10 has a significant drug interaction with warfarin, as it may increase warfarin metabolism through selective interaction with cytochrome P450 enzymes, particularly in patients with heart conditions 1
Clinical evidence indicates that CoQ10 supplementation at 100 mg/day has no effect on the clinical action of warfarin, suggesting this interaction may be dose-dependent or less clinically significant than previously thought, according to the American College of Clinical Pharmacology 1
The clinical approach recommended by the American College of Cardiology is to avoid CoQ10 or monitor INR more frequently if supplementation is deemed necessary, particularly at doses above 100 mg/day, for patients on warfarin 1

The National Institutes of Health states that CoQ10 demonstrates remarkable safety with minimal adverse effects even at very high doses, with doses up to 3000 mg/day for 8 months being well-tolerated in patients with neurological conditions 1
The European Food Safety Authority recommends monitoring liver enzymes in patients on CoQ10 supplementation, particularly at higher doses or with prolonged use, as elevated liver enzymes have been reported 2, 4

The American Association for Clinical Chemistry suggests monitoring liver enzymes in patients on CoQ10 supplementation, particularly at higher doses or with prolonged use 2, 4
The American College of Clinical Pharmacology recommends increasing INR monitoring frequency for patients on warfarin who require CoQ10, especially when initiating or changing doses 1

The World Health Organization states that CoQ10 supplementation appears safe across various disease states, including neurological conditions, cardiovascular disease, and chronic fatigue syndrome, with no specific population-based contraindications identified 1